Verrica Pharmaceuticals Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Verrica Pharmaceuticals Inc. (VRCA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number of 500.80 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber · last filed 2026-08-06
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 500.80K shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 473.43K shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 299.79K shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 236.41K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number |
|---|---|
| 2026-06-30 | 500.80K shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 473.43K shares 10-Q · filed 2026-05-12 |
| 2025-12-31 | 299.79K shares 10-K · filed 2026-03-11 |
| 2025-09-30 | 236.41K shares 10-Q · filed 2025-11-14 |
| 2025-06-30 | 233.31K shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 1.95M shares 10-Q · filed 2025-05-13 |
| 2024-09-30 | 3.83M shares 10-Q · filed 2024-11-05 |
| 2024-06-30 | 3.65M shares 10-Q · filed 2024-08-14 |
| 2024-03-31 | 3.44M shares 10-Q · filed 2024-05-13 |
| 2023-09-30 | 2.90M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 2.72M shares 10-Q · filed 2023-08-08 |
| 2023-03-31 | 2.56M shares 10-Q · filed 2023-05-09 |
| 2022-09-30 | 2.14M shares 10-Q · filed 2022-11-07 |
| 2022-06-30 | 2.13M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 1.97M shares 10-Q · filed 2022-05-09 |
| 2021-09-30 | 1.74M shares 10-Q · filed 2021-11-12 |
| 2021-06-30 | 1.51M shares 10-Q · filed 2021-08-10 |
| 2021-03-31 | 1.40M shares 10-Q · filed 2021-05-07 |
| 2020-09-30 | 975.63K shares 10-Q · filed 2020-11-09 |
| 2020-06-30 | 912.59K shares 10-Q · filed 2020-08-05 |
| 2020-03-31 | 788.87K shares 10-Q · filed 2020-05-07 |
| 2019-06-30 | 474.73K shares 10-Q · filed 2019-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |